Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid addiction in the United States.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...